Duchenne Drug Delayed After Outrage Over Price
Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.
Read more on NPR
Health Care - February 15, 2017 at 02:15AM - Duchenne Drug Delayed After Outrage Over Price
Không có nhận xét nào:
Đăng nhận xét